Intracranial tumors in the COVID-19 era: how the pandemic has changed patient management

A prospective study in the UK has provided new insights into how the COVID-19 pandemic has affected the management of patients with intracranial tumors.

“The COVID-19 pandemic has profoundly affected cancer services,” according to Dr Daniel Fountain of the University of Manchester in Manchester, UK. “Our objective was to determine the effect of the COVID-19 pandemic on decision making and the resulting outcomes for patients with newly diagnosed or recurrent intracranial tumors.”

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.